Biotechnology Market Research Reports & Industry Analysis
Biotechnology is a rapidly evolving industry that holds immense potential for growth and innovation across a wide range of product applications and markets. At MarketResearch.com, we offer a variety of biotechnology market research reports that provide valuable insights and data on key market segments across the world.
Biotech Market Research to Fuel Business Growth
Our reports answer critical questions about the biotechnology market to help guide your business strategies. Our research covers:
- Current market performance, industry outlooks, and industry lifecycles
- Expert analysis of supply chains, products and services, market drivers and challenges, and major markets to watch
- Market share information, profiles of established and emerging players, discussion of key success factors, and financial benchmarking
- Insights into new technologies and patents, pipeline analysis, data on revenue fluctuations, and overviews of regulations & policies
Stay Ahead with our Biotechnology Industry Analysis
The biotechnology market is advancing at a fast pace, with new technologies and products emerging all the time. Our reports help businesses stay up to date on these changes and identify new opportunities for growth. With our trusted reputation and commitment to quality, MarketResearch.com is the ideal source for biotechnology market research reports written by experienced analysts with extensive knowledge of the industry. MarketResearch.com has been a trusted source for business intelligence for over 20 years, and our long-time clients include many leading companies in the life sciences. If you need assistance, our team of knowledgeable research specialists are always available to help expedite the process.
Biotechnology Industry Research & Market Reports
-
Cancer Stem Cells
... by 2030, growing at a CAGR of 8.3% over the analysis period 2023-2030. Stem Cell-based Cancer Therapy, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$1.3 ... Read More
-
Immunohistochemistry
... of 7.1% over the analysis period 2023-2030. Immunohistochemistry Antibodies, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$1.9 Billion by the end of the analysis period. ... Read More
-
Automated Microscopy
... at a CAGR of 7.0% over the analysis period 2023-2030. Optical Microscopes, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$8.8 Billion by the end of ... Read More
-
Photopheresis Products
... at a CAGR of 5.4% over the analysis period 2023-2030. Photopheresis Open System, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$164.4 Million by the end ... Read More
-
Breast Cancer Liquid Biopsy
... reach US$1.1 Billion by 2030, growing at a CAGR of 21.4% over the analysis period 2023-2030. Reagent Kits, one of the segments analyzed in the report, is expected to record a 22.0% CAGR and reach ... Read More
-
Cancer Immunotherapy Drug Discovery Outsourcing
... is expected to reach US$4.0 Billion by 2030, growing at a CAGR of 13.7% over the analysis period 2023-2030. Monoclonal Antibodies, one of the segments analyzed in the report, is expected to record a 13.1% ... Read More
-
Genomics in Cancer Care
... reach US$62.1 Billion by 2030, growing at a CAGR of 16.5% over the analysis period 2023-2030. Instruments, one of the segments analyzed in the report, is expected to record a 15.1% CAGR and reach US$25.0 ... Read More
-
High Throughput Process Development
... reach US$24.6 Billion by 2030, growing at a CAGR of 8.3% over the analysis period 2023-2030. Monoclonal Antibodies Molecule Type, one of the segments analyzed in the report, is expected to record a 9.0% CAGR ... Read More
-
Terahertz Technology
... at a CAGR of 28.9% over the analysis period 2023-2030. Terahertz Source Technology, one of the segments analyzed in the report, is expected to record a 29.1% CAGR and reach US$1.8 Billion by the end ... Read More
-
Organs-on-Chips
... of 35.3% over the analysis period 2023-2030. Liver-on-Chip, one of the segments analyzed in the report, is expected to record a 36.6% CAGR and reach US$206.0 Billion by the end of the analysis period. Growth ... Read More
-
Technical Enzymes
... at a CAGR of 4.2% over the analysis period 2023-2030. Amylases, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$564.8 Million by the end of the ... Read More
-
Alpha Mannosidosis
... at a CAGR of 11.3% over the analysis period 2023-2030. Bone Marrow Transplant (BMT), one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$6.3 Billion by the ... Read More
-
Cold Plasma
... at a CAGR of 14.7% over the analysis period 2023-2030. Polymer & Plastics End-Use, one of the segments analyzed in the report, is expected to record a 13.9% CAGR and reach US$1.7 Billion by the ... Read More
-
High-Resolution Melting Analysis
... by 2030, growing at a CAGR of 2.9% over the analysis period 2023-2030. Other Applications, one of the segments analyzed in the report, is expected to record a 1.4% CAGR and reach US$31.1 Million by ... Read More
-
MRSA Drugs
... at a CAGR of 4.4% over the analysis period 2023-2030. Glycopeptides & Lipoglycopeptides, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$726.5 Million by the end ... Read More
-
NGS-Based RNA-Sequencing
... at a CAGR of 20.2% over the analysis period 2023-2030. Sequencing Platforms & Consumables, one of the segments analyzed in the report, is expected to record a 20.7% CAGR and reach US$5.1 Billion by the ... Read More
-
GMP Cell Banking Services
... reach US$2.2 Billion by 2030, growing at a CAGR of 15.0% over the analysis period 2023-2030. Biopharmaceutical Companies End-Use, one of the segments analyzed in the report, is expected to record a 14.6% CAGR and ... Read More
-
Gynecological Cancer Drugs
... by 2030, growing at a CAGR of 5.1% over the analysis period 2023-2030. Cervical Cancer Drugs, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$10.3 Billion ... Read More
-
Nanomedicine
... of 9.8% over the analysis period 2023-2030. Regenerative Medicine Application, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$229.6 Billion by the end of the analysis ... Read More
-
Human Microbiome
... at a CAGR of 28.4% over the analysis period 2023-2030. Gastrointestinal Diseases, one of the segments analyzed in the report, is expected to record a 28.7% CAGR and reach US$1.3 Billion by the end of ... Read More
-
Neurological Biomarkers for Alzheimer`s and Parkinson`s Diseases
... US$9.1 Billion in the year 2023, is expected to reach US$16.4 Billion by 2030, growing at a CAGR of 8.7% over the analysis period 2023-2030. The U.S. Market is Estimated at US$2.5 Billion While China ... Read More
-
Newborn Screening
... at a CAGR of 7.1% over the analysis period 2023-2030. Newborn Screening Consumables, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$1.4 Billion by the end ... Read More
-
Computational Biology
... at a CAGR of 18.1% over the analysis period 2023-2030. Contract Services, one of the segments analyzed in the report, is expected to record a 19.2% CAGR and reach US$20.1 Billion by the end of ... Read More
-
Humanized Mouse and Rat Model
... is expected to reach US$219.4 Million by 2030, growing at a CAGR of 7.5% over the analysis period 2023-2030. Oncology Application, one of the segments analyzed in the report, is expected to record a 8.1% ... Read More
-
Hydrophobic Interaction Chromatography
... a CAGR of 6.3% over the analysis period 2023-2030. Chromatography Resins, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$263.1 Million by the end of the ... Read More
Research Assistance
